Open Access

Live Q&A session, Meeting Summary & Close.

Topic: Cardiac Amyloidosis
Sponsored by Alnylam Pharmaceuticals

Congress Session

1 more presentation in this session

Transforming Outcomes for Patients with hATTR Amyloidosis.

Speaker: Doctor C. Whelan (London, GB) Doctor O. Akinboboye (New York, US)

Thumbnail

Access the full session

Transforming Outcomes for Patients with hATTR Amyloidosis

Speakers: Doctor C. Whelan, Doctor O. Akinboboye
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - panel .

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

Open Access

Transforming Outcomes for Patients with hATTR Amyloidosis.

27 August 2021

This platform is supported by

logo Novo Nordisk